This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Jansen, R W Articles by Averett, D R Search for Related Content PubMed PubMed Citation Articles by Jansen, R W Articles by Averett, D R

 Previous Article  |  Next Article 

Antimicrob Agents Chemother. 1993 March; 37(3): 441-447

High-capacity in vitro assessment of anti-hepatitis B virus compound selectivity by a virion-specific polymerase chain reaction assay.

Division of Experimental Therapy, Burroughs Wellcome Co., Research Triangle Park, North Carolina 27709.

ABSTRACT

An integrated assessment system specific for hepatitis B virus (HBV) Dane particle DNA was developed to examine the activity of potential anti-HBV compounds in chronic HBV-producing HepG2-derived 2.2.15 cells. Cell culture, immunoaffinity purification, polymerase chain reaction, and hybrid-capture detection were performed in the microtiter format to facilitate increased throughput by automation. The high sensitivity afforded by the assay provided quantitative detection of less than 0.5 fg of extracellular HBV DNA from 25 microliters of cell culture supernatants, and drug-induced reductions in HBV titers greater than 100-fold were easily measured. Fluorometric determination of total cellular DNA from the same 96-well proliferating cell cultures allowed simultaneous evaluation of inhibition of cell growth, thus providing the ability to assess the overall selectivities of candidate compounds in a single experiment. The potent activities of three anti-HBV compounds, the (+) and (-) enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxythiolane-5-yl]cytosine (FTC) and D-carbocyclic-2'-deoxyguanosine (CDG), were confirmed by this method. (-)-FTC was more active than its (+) enantiomer (50% inhibitory concentrations, 0.033 +/- 0.006 and 0.723 +/- 0.160 microM [standard error of the mean; SEM], respectively), while both enantiomers demonstrated a lack of cytotoxicity at 200 microM. CDG was more potent (50% inhibitory concentration, 0.0063 +/- 0.0007 microM [SEM]) but was also significantly more toxic, inhibiting cell growth by 50% at 32 +/- 6 microM (SEM). These results demonstrate the usefulness of this immunoaffinity-based, quantitative polymerase chain reaction system as a high-capacity in vitro tool for assessment of anti-HBV compound selectivity.

This article has been cited by other articles:

• Walters, K.-A., Tipples, G. A., Allen, M. I., Condreay, L. D., Addison, W. R., Tyrrell, L. (2003). Generation of Stable Cell Lines Expressing Lamivudine-Resistant Hepatitis B Virus for Antiviral-Compound Screening. Antimicrob. Agents Chemother. 47: 1936-1942 [Abstract] [Full Text]  
• Gaillard, R. K., Barnard, J., Lopez, V., Hodges, P., Bourne, E., Johnson, L., Allen, M. I., Condreay, P., Miller, W. H., Condreay, L. D. (2002). Kinetic Analysis of Wild-Type and YMDD Mutant Hepatitis B Virus Polymerases and Effects of Deoxyribonucleotide Concentrations on Polymerase Activity. Antimicrob. Agents Chemother. 46: 1005-1013 [Abstract] [Full Text]  
• Fu, L., Cheng, Y.-C. (2000). Characterization of Novel Human Hepatoma Cell Lines with Stable Hepatitis B Virus Secretion for Evaluating New Compounds against Lamivudine- and Penciclovir-Resistant Virus. Antimicrob. Agents Chemother. 44: 3402-3407 [Abstract] [Full Text]  
• Tam, R. C., Ramasamy, K., Bard, J., Pai, B., Lim, C., Averett, D. R. (2000). The Ribavirin Analog ICN 17261 Demonstrates Reduced Toxicity and Antiviral Effects with Retention of both Immunomodulatory Activity and Reduction of Hepatitis-Induced Serum Alanine Aminotransferase Levels. Antimicrob. Agents Chemother. 44: 1276-1283 [Abstract] [Full Text]  
• Allen, M. I., Gauthier, J., DesLauriers, M., Bourne, E. J., Carrick, K. M., Baldanti, F., Ross, L. L., Lutz, M. W., Condreay, L. D. (1999). Two Sensitive PCR-Based Methods for Detection of Hepatitis B Virus Variants Associated with Reduced Susceptibility to Lamivudine. J. Clin. Microbiol. 37: 3338-3347 [Abstract] [Full Text]